JP2015193630A5 - - Google Patents

Download PDF

Info

Publication number
JP2015193630A5
JP2015193630A5 JP2015104213A JP2015104213A JP2015193630A5 JP 2015193630 A5 JP2015193630 A5 JP 2015193630A5 JP 2015104213 A JP2015104213 A JP 2015104213A JP 2015104213 A JP2015104213 A JP 2015104213A JP 2015193630 A5 JP2015193630 A5 JP 2015193630A5
Authority
JP
Japan
Prior art keywords
sodium salt
salt dihydrate
crystalline genistein
genistein sodium
peaks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015104213A
Other languages
English (en)
Japanese (ja)
Other versions
JP6067781B2 (ja
JP2015193630A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015193630A publication Critical patent/JP2015193630A/ja
Publication of JP2015193630A5 publication Critical patent/JP2015193630A5/ja
Application granted granted Critical
Publication of JP6067781B2 publication Critical patent/JP6067781B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015104213A 2008-12-11 2015-05-22 ゲニステインの結晶形 Expired - Fee Related JP6067781B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12177808P 2008-12-11 2008-12-11
US12178708P 2008-12-11 2008-12-11
US61/121,787 2008-12-11
US61/121,778 2008-12-11

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011540919A Division JP5898958B2 (ja) 2008-12-11 2009-12-11 ゲニステインの結晶形

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016247753A Division JP2017061566A (ja) 2008-12-11 2016-12-21 ゲニステインの結晶形

Publications (3)

Publication Number Publication Date
JP2015193630A JP2015193630A (ja) 2015-11-05
JP2015193630A5 true JP2015193630A5 (enExample) 2016-01-28
JP6067781B2 JP6067781B2 (ja) 2017-01-25

Family

ID=42243089

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2011540919A Expired - Fee Related JP5898958B2 (ja) 2008-12-11 2009-12-11 ゲニステインの結晶形
JP2015104213A Expired - Fee Related JP6067781B2 (ja) 2008-12-11 2015-05-22 ゲニステインの結晶形
JP2016247753A Pending JP2017061566A (ja) 2008-12-11 2016-12-21 ゲニステインの結晶形

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2011540919A Expired - Fee Related JP5898958B2 (ja) 2008-12-11 2009-12-11 ゲニステインの結晶形

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016247753A Pending JP2017061566A (ja) 2008-12-11 2016-12-21 ゲニステインの結晶形

Country Status (11)

Country Link
US (2) US9012495B2 (enExample)
EP (1) EP2373326B1 (enExample)
JP (3) JP5898958B2 (enExample)
KR (2) KR101849059B1 (enExample)
CN (2) CN102292097B (enExample)
AU (1) AU2009324489B2 (enExample)
BR (1) BRPI0923504A2 (enExample)
CA (1) CA2746652C (enExample)
IL (2) IL213473A (enExample)
WO (1) WO2010068861A1 (enExample)
ZA (1) ZA201105045B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010068861A1 (en) 2008-12-11 2010-06-17 Axcentua Pharmaceutucals Ab Crystalline forms of genistein
US7863325B2 (en) 2008-12-11 2011-01-04 Axcentua Pharmaceuticals Ab Crystalline genistein sodium salt dihydrate
WO2011104667A1 (en) * 2010-02-25 2011-09-01 Anthem Biosciences Private Limited Basic aminoacid salts of polyphenols
CN102442990B (zh) * 2010-10-12 2015-03-11 上海睿智化学研究有限公司 一种金雀异黄素烟酰胺共晶、其晶体及其制备方法
CN102442991B (zh) * 2010-10-12 2015-03-11 上海睿智化学研究有限公司 一种金雀异黄素维生素b6共晶、其晶体及其制备方法
CN102442989B (zh) * 2010-10-12 2015-04-08 上海睿智化学研究有限公司 一种金雀异黄素盐、其晶体及其制备方法
CN105963246B (zh) * 2016-05-06 2018-12-25 荆楚理工学院 一种染料木素盐口服溶液剂及制备方法和应用
CN105853350A (zh) * 2016-05-24 2016-08-17 荆楚理工学院 一种染料木素溶液及制备方法和应用
CN109666014A (zh) * 2018-12-12 2019-04-23 荆门医药工业技术研究院 一种染料木素衍生物盐的制备方法及其应用
US20240058298A1 (en) 2020-12-03 2024-02-22 Delta 4 Gmbh Genistein for use in the treatment of focal segmental glomerulosclerosis (fsgs)
AU2023261942A1 (en) 2022-04-28 2024-09-19 GreenStone Biosciences, Inc. Treatment of the adverse cardiovascular effects of cannabinoids
US20250170154A1 (en) 2023-11-28 2025-05-29 GreenStone Biosciences, Inc. Genistein phosphate derivatives

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62201882A (ja) * 1985-11-18 1987-09-05 Yamanouchi Pharmaceut Co Ltd イソフラボン誘導体
USRE40792E1 (en) 1992-05-19 2009-06-23 Novogen Research Pty Ltd Health supplements containing phyto-oestrogens, analogues or metabolites thereof
DE4331233A1 (de) * 1993-09-15 1995-03-16 Basf Ag Verfahren zur Herstellung von Hydroxyoxaalkylmelaminen
US5569459A (en) * 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
US5554519A (en) 1995-08-07 1996-09-10 Fermalogic, Inc. Process of preparing genistein
PL179170B1 (pl) * 1995-09-15 2000-07-31 Inst Lekow Nowe zwiazki,pochodne genisteiny PL PL PL PL
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
WO1997030035A1 (en) 1996-02-13 1997-08-21 Zeneca Limited Quinazoline derivatives as vegf inhibitors
ES2169355T3 (es) 1996-03-05 2002-07-01 Astrazeneca Ab Derivados de 4-anilinoquinazolina.
GB9613455D0 (en) 1996-06-27 1996-08-28 Aston Molecules Ltd Analogues or derivatives of quercetin
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
US5981775A (en) 1998-09-16 1999-11-09 Board Of Trustees Operating Michigan State University Process for the preparation of isoflavones
US6194469B1 (en) * 1998-12-11 2001-02-27 Board Of Trustees Operating Michigan State Univeristy Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
AUPQ520300A0 (en) * 2000-01-21 2000-02-17 Novogen Research Pty Ltd Food product and process
IL152682A0 (en) 2000-05-31 2003-06-24 Astrazeneca Ab Indole derivatives with vascular damaging activity
ATE265858T1 (de) 2000-06-16 2004-05-15 Linnea Sa Wasserlöslicher komplex eines ginkgo biloba extrakts, verfahren zu dessen herstellung und diesen enthaltende zusammensetzung
HUP0301742A3 (en) 2000-07-07 2005-08-29 Angiogene Pharm Ltd Colchinol derivatives as angiogenesis inhibitors, process for producing them, pharmaceutical compositions containing them and their use
BR0112224A (pt) 2000-07-07 2003-06-10 Angiogene Pharm Ltd Composto, composição farmacêutica, uso de um composto ou de um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, e, processo para preparar um composto
US6541613B2 (en) * 2000-12-15 2003-04-01 Uyrex Corporation Isoflavone derivatives
PL205635B1 (pl) * 2001-04-09 2010-05-31 Inst Farmaceutyczny Nowe pochodne genisteiny i zawierające je środki farmaceutyczne
CN100348592C (zh) * 2001-12-28 2007-11-14 中国人民解放军第二军医大学 3，7，8－三取代－5－羟基苯并－γ－吡喃酮类化合物及其制备方法
US20040023981A1 (en) * 2002-07-24 2004-02-05 Yu Ren Salt forms with tyrosine kinase activity
RU2350611C1 (ru) 2002-12-24 2009-03-27 Астразенека Аб Производные фосфонооксихиназолина и их фармацевтическое применение
JP5017103B2 (ja) * 2004-06-17 2012-09-05 トランスフオーム・フアーマシユーチカルズ・インコーポレーテツド 薬剤共結晶組成物および関連した使用方法
ATE473737T1 (de) * 2004-07-20 2010-07-15 Furfural Espanol S A Verwendung von 2,3-dehydronaringenin-derivaten zur behandlung von entzündungsprozessen und diese derivate enthaltende pharmazeutische zusammensetzung
JP5566008B2 (ja) 2005-02-15 2014-08-06 ディーエスエム アイピー アセッツ ビー．ブイ． 多糖類含有組成物
US8951560B2 (en) * 2005-06-29 2015-02-10 Dsm Ip Assets B.V. Isoflavone nanoparticles and use thereof
WO2007022138A2 (en) 2005-08-11 2007-02-22 The Scripps Research Institute Genistein inhibition of transthyretin amyloidosis
WO2007061254A1 (en) 2005-11-25 2007-05-31 B & C Biopharm. Co., Ltd. Genistein derivatives and anti-fungal composition containing the same
WO2008034016A2 (en) * 2006-09-15 2008-03-20 Foldrx Pharmaceuticals, Inc. Assays for detecting native-state proteins and identifying compounds that modulate the stability of native-state proteins
JP2008094751A (ja) * 2006-10-11 2008-04-24 Ono Pharmaceut Co Ltd プランルカスト水和物含有医薬組成物
WO2010068861A1 (en) 2008-12-11 2010-06-17 Axcentua Pharmaceutucals Ab Crystalline forms of genistein

Similar Documents

Publication Publication Date Title
JP2013237682A5 (enExample)
JP2017061566A5 (enExample)
HRP20250119T1 (hr) Kdm1a inhibitor i njegova primjena u terapiji
EA201592250A1 (ru) Пиразолопирролидиновые производные и их применение в лечение заболеваний
JP2016508134A5 (enExample)
EA201592256A1 (ru) Производные имидазопирролидинона и их применение при лечении заболеваний
MX2022001863A (es) Metodos para tratar los tumores del estroma gastrointestinal.
JP2017524735A5 (enExample)
PH12015501517A1 (en) Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease
JP2013509429A5 (enExample)
JP2016515561A5 (enExample)
JP2012082234A5 (enExample)
IL295418B1 (en) Beta-d-2'-deoxy-2' alpha-fluoro-2'-bata-c-modified-2-different-n6-purine modified nucleotides for the treatment of hepatitis c virus
JP2016501221A5 (enExample)
EA201691058A1 (ru) Производные пирролопирролона и их применение для лечения заболеваний
TN2015000293A1 (en) Heterocycle-substituted tetracyclic compounds and methods of use thereof for treatment of viral diseases
MX2015016421A (es) Derivados de pirazolo-pirrolidin-4-ona como inhibidores de bet y su uso en el tratamiento de enfermedades.
HRP20171648T1 (hr) Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze
EA201592254A1 (ru) Производные пиразолопирролидин-4-она и их применение при лечении заболевания
JP2012512164A5 (enExample)
IL311873A (en) Combination therapy for treating malignancies
JP2015516419A5 (enExample)
NZ758449A (en) Heteroaromatic compounds useful in therapy
JP2015537009A5 (enExample)
BR112015016184A2 (pt) derivados de piridona e seu uso no tratamento, melhora ou prevenção de uma doença viral